*  Exposure Controls/Personal Protection  *
Respiratory Protection:UNDER NORMAL MANUFACTURING CONDITIONS,  NO
    RESPIRATORY PROTECTION IS REQUIRED WHEN USING THIS PRODUCT.
    SELF-CONTAINED BREATHING APPARATUS (SCBA) IS REQUIRED IF LARGE
    RELEASE OCCURS.
Ventilation:USE SUFFICIENT VENTILATION TO KEEP WORKER EXPOSURE BELOW
    RECOMMENDED EXPOSURE LIMITS. LOCAL EXHAUST FOR LARGE AMOUNTS .
    MECHANICAL IN LOW OR ENCLOSED PLACES.
Work Hygienic Practices:LAUNDER CONTAMINATED CLOTHING BEFORE REUSE.
Supplemental Safety and Health
*  Product Identification  *
*  Composition/Information on Ingredients  *
Other REC Limits:NONE RECOMMENDED
Ozone Depleting Chemical:2
Other REC Limits:NONE RECOMMENDED
Other REC Limits:NONE RECOMMENDED
*  Hazards Identification  *
Routes of Entry: Inhalation:YES  Skin:YES  Ingestion:NO
Reports of Carcinogenicity:NTP:NO    IARC:NOOSHA:NO
Health Hazards Acute and Chronic:INHALATION OF HIGH VAP0R CONCENTRATION
    IS HARMFUL & MAY CAUSE HEART IRREGULARITIES, UNCONSCIOUSNESS, OR
    DEATH. INTENTINAL MISUSE/DELIBERATE INHALATION MAY CAUSE DEATH
    WITHOUT WARNING. VAPOR REDUCES OX YGEN AVAILABLE FOR BREATHING & IS
    HEAVIER THAN AIR. LIQUID CONTACT CAN CAUSE FROSTBITE.
Explanation of Carcinogenicity:NONE OF THE COMPONENTS PRESENT AT
    CONCENTRATIONS EQUAL TOOR GREATER THAN0.1% ARE LISTED BY
    IARC,NTP,OSHA OR ACGIH AS A CARCINOGEN.
Effects of Overexposure:SKIN CONTACT MAY CAUSE FROSTBITE FROM EXPOSURE
    TO THE LIQUID. INHALATION MAY INCLUDE NONSPECIFIC DISCOMFORT, SUCH
    AS NAUSEA, OR WEAKNESS; OR TEMPORARY NERVOUS SYSTEM DEPRESSION WITH
    ANESTHETIC EFFECTSSUCH AS DIZZINESS, HEADACHE,
    CONFUSION,INCOORDINATION, & LOSS OF CONSCIOUSNESS. HIGHER EXPOSURES
    TO VAPORS MAY LEAD OF THESE EFFECTS: TEMPORARY LUNG IRRITATION
    EFFECTS WITH COUGH, DISCOMFORT, DIFFICU LTY BREATHING, TEMPORARY
    ALTERATION OF THE HEART'S ELECTRICAL ACTIVITY WITH IRREGULAR PULSE,
    PALPITATIONS, OR INADEQUATE CIRCULATION, ABNORMAL KIDNEY FUNCTION
    OR FATALITY.
Medical Cond Aggravated by Exposure:INDIVIDUALS WITH PRE-EXISTING
    DISEASES OF THE CENTRAL NERVOUS OR CARDIOVASCULAR SYSTEM, LUNGS OR
    KIDNEYS MAY HAVE INCREASE SUSCEPTIBILITY TO TOXICITY OF EXCESSIVE
    EXPOSURES.
*  First Aid Measures  *
First Aid:INHALATION-IF HIGHER CONCENTRATIONS  ARE INHALED, IMMEDIATELY
     REMOVE TO FRESH AIR. KEEP PERSON CALM. IF NOT BREATHING, GIVE
    ARTIFICIAL RESPIRATION. IF BREATHING DIFFICULT, GIVE OXYGEN. CALL A
    ASSISTANCE IF IRRITATION PERSISTS. TREAT FOR FROSTBITE IF NEEDED BY
    GENTLY WARMING AFFECTED AREA. EYES- IMMEDIATELYFLUSH EYES WITH
    CONSIDERED POTENTIAL EXPOSURE  ROUTE.
*  Fire Fighting Measures  *
Flash Point Method:TOC
Flash Point:WILL NOT BURN
Extinguishing Media:USE MEDIA APPROPRIATE FRO SURROUNDING MATERIAL.
Fire Fighting Procedures:COOL TANK/CONTAINER WITH WATER SPRAY.
    SELF-CONTAINED BREATHING APPARATUS (SCBA) MAY BE REQUIRED IF
    CYLINDERS RUPTURE OR RELEASE PRODUCT UNDER FIRE CONDITIONS.
Unusual Fire/Explosion Hazard:CYLINDERS MAY RUPTURE UNDER FIRE
    CONDITIONS. DECOMPOSITION  MAY OCCUR.
*  Accidental Release Measures  *
Spill Release Procedures:COMPLY WITH FEDERAL, STATE, LOCAL REGULATIONS
    FOR REPORTING RELEASES. USE APPROPR RIATE PERSONAL PROTITIVE
    EQUIPMENT DURING CLEAN-UP. VENTILATE AREA, ESPECIALLY LOW OR
    ENCLOSED PLACES WHERE HEAVY VAPA PORS MIGHT COLLECT. REMOVE OPEN
    FLAMES.USE SELF-CONTAINED BREATHING APPARATUS (SCBA) IF LARGE SPILL
    OR LEAK OCCURS.
*Handling and Storage  *
Handling and Storage Precautions:AVOID BREATHING VAPORS OR MIST. AVOID
    CONTACT WITH EYES OR SKIN. USE WITH SUFFICIENT VENTILATION TO KEEP
    WORKER EXPOSURE  BELOW RECOMMENDED LIMITS. STORE IN A CLEAN, DRY
Other Precautions:REFRIGERANT CONCENTRATION MONITORS MAY BE NECESSARY
    TO DETERMINE VAPOR CONCENTRATIONS IN WORK AREAS, PRIOR TO USE OF
    TORCHES OR OTHER OPEN FLAMES, OR IF WORKERS ENTER ENCLOSEDAREAS.
*  Physical/Chemical Properties  *
HCC:G3
Melt/Freeze Pt:M.P/F.P Text:NP
Decomp Temp:Decomp Text:NP
pH:NP
Viscosity:NP
Evaporation Rate & Reference:>1, CCL4=1.0
Appearance and Odor:CLEAR, COLORLESS LIQUIFIED GAS, ETHER (SLIGHT) ODOR
Corrosion Rate:NP
*  Stability and Reactivity Data  *
Stability Indicator/Materials to Avoid:YES
INCOMPATIBLE WITH ALKALI OR ALKALINE EARTH METALS-POWDERED AL, ZN, BE,
    ETC.
Stability Condition to Avoid:AVOID OPEN FLAMES AND HIGH TEMPERATURES.
Hazardous Decomposition Products:CAN DECOMPOSE BY HIGH TEMPERATURES
    (OPEN FLAMES, GLOWING METAL SURFACES, ETC) FORMING HYDROCHLORIC AND
    HYDROFLUORIC ACIDS, AND POSSIBLY CARBONYL HALIDES.
Conditions to Avoid Polymerization:WILL NOT OCCUR.
*  Toxicological Information*
Toxicological Information:ANIMAL DATA: THE BLEND IS UNTESTED.
    PPM IN RATS. THE COMPOUND ISA SKIN IRRITANT AND A SLIGHT EYE
    IRRITANT, BUT IS NOT A SKIN SENSITIZER  IN ANIMALS. EFFECTS FROM
    SINGLE HIGH EXPOSURES INCLUDE CENTRAL NERVOUS SYSTEM DEPRESSION,
    ANESTHESIA, RAPID BREATHING, LUNG CONGESTION AND MICROSCOPIC LIVER
    GREATER FROM THE ACTION OF EXOGENOUS EPINEPHRINE.
*  Ecological Information  *
    MG/L.
*  Disposal Considerations  *
Waste Disposal Methods:TREATMENT, STORAGE, TRANSPORTATION AND DIAPOSAL
    MUST BE IN ACCORDANCE WITH APPLICABLE FEDERAL, STATE, PROVINCIAL,
    AND LOCAL REGULATIONS. RECOVER BY DISTILLATION OR REMOVE TO A
    PERMITTED WASTE DISPOSAL  FACILITY.
*  MSDS Transport Information  *
Transport Information:DOT/IMO PROPER SHIPPING NAME: LIQUEFIEDGAS,
    N.O.S. (CHLORODIFLUOROMETHANE AND CHLOROTETRAFLUOROETHANE). HAZARD
*  Regulatory Information  *
SARA Title III Information:ACUTE: YES. CHRONIC: NO. FIRE: NO.
    REACTIVITY: NO. PRESSURE: YES. SARA EXTREMELY HAZARDOUS
    SUBSTANCE:NO.
Federal Regulatory Information:TSCA INVENTORY STATUS:
    REPORTED/INCLUDED. CERCLA HAZARDOUS SUBSTANCE: NO.
*  Other Information  *
